OrthoPediatrics (KIDS) Misses Q1 EPS by 4c

OrthoPediatrics (NASDAQ: KIDS) reported Q1 EPS of ($0.21), $0.04 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $14.7 million versus the consensus estimate of $14.71 million.

Full Year 2019 Financial Guidance

OrthoPediatrics is reiterating financial guidance for the full year 2019, as follows:

• Revenue growth in a range of 21.0% to 23.0%
• Consigned set investments in a range of $15.0 million to $17.0 million

For earnings history and earnings-related data on OrthoPediatrics (KIDS) click here.

You May Also Be Interested In

• Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
• Klarna Group plc (KLAR) Tops Q2 EPS by 6c, Beats on Revenue; Offers FY26 Revenue Guidance
• Prenetics Global (PRE) Tops Q2 EPS by 18c